A recent study indicates that odors present in earwax may offer a way to distinguish individuals with Parkinson’s disease (PD) from those without the condition. The research highlights the potential for a novel, non-invasive diagnostic approach.

Researchers identified four volatile organic compounds (VOCs) in ear canal secretions that showed significant differences between participants with and without PD. These compounds-ethylbenzene, 4-ethyltoluene, pentanal, and 2-pentadecyl-1,3-dioxolane-could serve as potential biomarkers. An artificial intelligence olfactory (AIO)-based screening model,utilizing